HN2002000197A - Proceso para la produccion de quinazolinas - Google Patents
Proceso para la produccion de quinazolinasInfo
- Publication number
- HN2002000197A HN2002000197A HN2002000197A HN2002000197A HN2002000197A HN 2002000197 A HN2002000197 A HN 2002000197A HN 2002000197 A HN2002000197 A HN 2002000197A HN 2002000197 A HN2002000197 A HN 2002000197A HN 2002000197 A HN2002000197 A HN 2002000197A
- Authority
- HN
- Honduras
- Prior art keywords
- quinazolins
- production
- useful
- compounds
- quinazoline compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A UN NUEVO PROCESO PARA PRODUCIR COMPUESTOS DE QUINAZOLINA QUE SON UTILES EN TERAPIA.- MAS ESPECIFICAMENTE, LOS COMPUESTOS SON ÚTILES EN EL TRATAMIENTO DE LA HIPERPLASIA PROSTATICA BENIGNA. COMPUESTOS DE QUINOLINA Y QUINAZOLINA SUSTITUTIDAS (VER FORMULA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0118752.5A GB0118752D0 (en) | 2001-08-01 | 2001-08-01 | Process for the production of quinazolines |
Publications (1)
Publication Number | Publication Date |
---|---|
HN2002000197A true HN2002000197A (es) | 2003-02-27 |
Family
ID=9919612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HN2002000197A HN2002000197A (es) | 2001-08-01 | 2002-07-29 | Proceso para la produccion de quinazolinas |
Country Status (27)
Country | Link |
---|---|
US (1) | US7026479B2 (es) |
EP (1) | EP1412331B1 (es) |
JP (1) | JP2005501054A (es) |
KR (1) | KR20040019097A (es) |
CN (1) | CN1533378A (es) |
AP (1) | AP1299A (es) |
AR (1) | AR036204A1 (es) |
AT (1) | ATE323677T1 (es) |
BR (1) | BR0211670A (es) |
CA (1) | CA2451075A1 (es) |
CZ (1) | CZ2004151A3 (es) |
DE (1) | DE60210778T2 (es) |
DO (1) | DOP2002000443A (es) |
EG (1) | EG23204A (es) |
ES (1) | ES2260457T3 (es) |
GB (1) | GB0118752D0 (es) |
HN (1) | HN2002000197A (es) |
HU (1) | HUP0401573A3 (es) |
IL (1) | IL158998A0 (es) |
MX (1) | MXPA04000978A (es) |
PA (1) | PA8550301A1 (es) |
PE (1) | PE20030346A1 (es) |
PL (1) | PL368520A1 (es) |
RU (1) | RU2261861C1 (es) |
UY (1) | UY27399A1 (es) |
WO (1) | WO2003011829A1 (es) |
ZA (1) | ZA200309043B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2400339T3 (es) * | 2002-07-15 | 2013-04-09 | Symphony Evolution, Inc. | Compuestos, composiciones farmacéuticas de los mismos y su uso en el tratamiento del cáncer |
JP4638436B2 (ja) | 2003-09-26 | 2011-02-23 | エグゼリクシス, インコーポレイテッド | c−Metモジュレーターおよびその使用 |
CA2565812C (en) * | 2004-05-06 | 2012-03-13 | Warner-Lambert Company Llc | 4-phenylamino-quinazolin-6-yl-amides |
WO2008015270A1 (en) * | 2006-08-04 | 2008-02-07 | Merz Pharma Gmbh & Co. Kgaa | Pyrazolopyrimidines, a process for their preparation and their use as medicine |
TWI577664B (zh) | 2009-01-16 | 2017-04-11 | 艾克塞里克斯公司 | N-(4-{〔6,7-雙(甲氧基)喹啉-4-基〕氧基}苯基)-n’-(4-氟苯基)環丙烷-1,1-二甲醯胺蘋果酸鹽、包含其之醫藥組合物及其用途 |
JP5795304B2 (ja) | 2009-03-18 | 2015-10-14 | レスバーロジックス コーポレイション | 新規抗炎症剤 |
IN2012DN00352A (es) * | 2009-06-16 | 2015-08-21 | Bikam Pharmaceuticals Inc | |
UA108618C2 (uk) | 2009-08-07 | 2015-05-25 | Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку | |
US9353063B2 (en) | 2011-11-30 | 2016-05-31 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
CN104884427B (zh) * | 2012-10-15 | 2016-09-07 | 雷斯韦洛吉克斯公司 | 可用于合成苯甲酰胺化合物的化合物 |
KR102662814B1 (ko) | 2015-03-13 | 2024-05-03 | 리스버로직스 코퍼레이션 | 보체 관련 질환을 치료하기 위한 조성물 및 치료 방법 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8719378D0 (en) * | 1987-08-15 | 1987-09-23 | Pfizer Ltd | Antiarrythmic agents |
EP0894797A4 (en) * | 1997-01-09 | 2001-08-16 | Terumo Corp | NEW AMID DERIVATIVES AND INTERMEDIATES ON YOUR SYNTHESIS |
-
2001
- 2001-08-01 GB GBGB0118752.5A patent/GB0118752D0/en not_active Ceased
-
2002
- 2002-07-11 PA PA20028550301A patent/PA8550301A1/es unknown
- 2002-07-19 RU RU2004102692/04A patent/RU2261861C1/ru not_active IP Right Cessation
- 2002-07-19 US US10/199,755 patent/US7026479B2/en not_active Expired - Fee Related
- 2002-07-19 IL IL15899802A patent/IL158998A0/xx unknown
- 2002-07-19 PL PL02368520A patent/PL368520A1/xx not_active Application Discontinuation
- 2002-07-19 CA CA002451075A patent/CA2451075A1/en not_active Abandoned
- 2002-07-19 MX MXPA04000978A patent/MXPA04000978A/es active IP Right Grant
- 2002-07-19 KR KR10-2004-7001513A patent/KR20040019097A/ko not_active Application Discontinuation
- 2002-07-19 EP EP02745749A patent/EP1412331B1/en not_active Expired - Lifetime
- 2002-07-19 WO PCT/IB2002/002872 patent/WO2003011829A1/en active IP Right Grant
- 2002-07-19 BR BR0211670-7A patent/BR0211670A/pt not_active IP Right Cessation
- 2002-07-19 CN CNA028143256A patent/CN1533378A/zh active Pending
- 2002-07-19 ES ES02745749T patent/ES2260457T3/es not_active Expired - Lifetime
- 2002-07-19 AT AT02745749T patent/ATE323677T1/de not_active IP Right Cessation
- 2002-07-19 HU HU0401573A patent/HUP0401573A3/hu unknown
- 2002-07-19 DE DE60210778T patent/DE60210778T2/de not_active Expired - Fee Related
- 2002-07-19 JP JP2003517021A patent/JP2005501054A/ja active Pending
- 2002-07-19 CZ CZ2004151A patent/CZ2004151A3/cs unknown
- 2002-07-23 DO DO2002000443A patent/DOP2002000443A/es unknown
- 2002-07-26 PE PE2002000678A patent/PE20030346A1/es not_active Application Discontinuation
- 2002-07-29 EG EG2002070853A patent/EG23204A/xx active
- 2002-07-29 HN HN2002000197A patent/HN2002000197A/es unknown
- 2002-07-29 UY UY27399A patent/UY27399A1/es not_active Application Discontinuation
- 2002-07-31 AR ARP020102914A patent/AR036204A1/es unknown
- 2002-08-01 AP APAP/P/2002/002602A patent/AP1299A/en active
-
2003
- 2003-11-20 ZA ZA200309043A patent/ZA200309043B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EG23204A (en) | 2004-07-31 |
GB0118752D0 (en) | 2001-09-26 |
BR0211670A (pt) | 2004-07-13 |
AR036204A1 (es) | 2004-08-18 |
IL158998A0 (en) | 2004-05-12 |
RU2261861C1 (ru) | 2005-10-10 |
DE60210778T2 (de) | 2007-01-04 |
AP2002002602A0 (en) | 2002-09-30 |
ES2260457T3 (es) | 2006-11-01 |
PE20030346A1 (es) | 2003-04-05 |
AP1299A (en) | 2004-09-06 |
ATE323677T1 (de) | 2006-05-15 |
JP2005501054A (ja) | 2005-01-13 |
CZ2004151A3 (cs) | 2005-01-12 |
EP1412331B1 (en) | 2006-04-19 |
CA2451075A1 (en) | 2003-02-13 |
PL368520A1 (en) | 2005-04-04 |
KR20040019097A (ko) | 2004-03-04 |
PA8550301A1 (es) | 2003-09-05 |
DE60210778D1 (de) | 2006-05-24 |
US20030100753A1 (en) | 2003-05-29 |
RU2004102692A (ru) | 2005-07-10 |
EP1412331A1 (en) | 2004-04-28 |
US7026479B2 (en) | 2006-04-11 |
HUP0401573A3 (en) | 2005-06-28 |
CN1533378A (zh) | 2004-09-29 |
UY27399A1 (es) | 2003-02-28 |
WO2003011829A1 (en) | 2003-02-13 |
MXPA04000978A (es) | 2004-04-20 |
ZA200309043B (en) | 2004-11-22 |
DOP2002000443A (es) | 2003-02-15 |
HUP0401573A2 (hu) | 2005-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY27234A1 (es) | Inhibidores novedosos de tirosina cinasa | |
IL258880A (en) | Compounds of diarylhydantoin | |
CR9427A (es) | Combinacion terapeutica en casos de hiperplasia prostatica benigna | |
HN2002000197A (es) | Proceso para la produccion de quinazolinas | |
WO2008046083A3 (en) | Use of oxindole compounds as therapeutic agents | |
CR7182A (es) | Benzoilsufanamidas y sulfonilbenzamidinas que se usan como agentes antitumorales | |
CR7332A (es) | INHIBIDORES DEL FACTOR Xa Y DE OTRAS PROTEASAS DE SERINA IMPLICADAS EN LA CASCADA DE LA COAGULACION | |
HRP20070567A2 (en) | Helix 12 directed non-steroidal antiandrogens | |
ECSP024382A (es) | Inhibidores de proteasa de serina | |
CY1107674T1 (el) | Φαρμακευτικος συνδυασμος για τη θεραπευτικη αντιμετωπιση της καλοηθους υπερπλασιας του προστατη ή για την μακροπροθεσμη προληψη της οξειας επισχεσης ουρων | |
BR122018009866B8 (pt) | métodos para preparar compostos de éter aminocicloexílico e compostos intermediários | |
WO2008046082A3 (en) | Use of heterocyclic compounds as therapeutic agents | |
DE602004011924D1 (de) | Chinazoline derivate und ihre anwendung in der krebsbehandlung | |
PA8525401A1 (es) | Compuestos farmaceuticos | |
BRPI0407913A (pt) | antagonistas receptores de ccr-3 | |
GT200100251A (es) | Procedimiento para la preparacion de imidazotriazinonas substituidas con sulfonamida | |
BR0109512A (pt) | Imidazopiridinas tricìclicas | |
BRPI0415678A (pt) | compostos de pirimidina para o tratamento de inflamação | |
DE602006020585D1 (de) | Neue cysteinproteasehemmer und ihre therapeutische anwendung | |
MX2008001838A (es) | Sales y polimorfos de un inhibidor de vegf-r. | |
HK1074840A1 (en) | Novel dithiolopyrrolones with therapeutic activity | |
SV2007002573A (es) | Proceso para la preparacion de inhibidores de tubulina | |
EA200401100A1 (ru) | 1α-ФТОР-25-ГИДРОКСИ-16,23E-ДИЕН-26,27-БИСГОМО-20-ЭПИХОЛЕКАЛЬЦИФЕРОЛ И ЕГО ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ | |
DK1521752T3 (da) | Makrocykliske forbindelser til behandling af cancer | |
GB0112061D0 (en) | Process for the production of quinazolines |